- Investing Ideas
- /
- Chinese Healthcare Undervalued based on future growth
Chinese Healthcare Undervalued based on future growth
Results
6
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
6 companies
Intco Medical Technology
Market Cap: CN¥14.7b
Engages in the research and development, production, and marketing of medical consumables, health care equipment, and physiotherapy care products that are used in medical and elderly care institutions, household daily use, and other related industries in China and internationally.
300677
CN¥22.88
7D
-1.5%
1Y
-8.6%
China National Accord Medicines
Market Cap: CN¥13.2b
China National Accord Medicines Corporation Ltd.
000028
CN¥25.48
7D
0.4%
1Y
-26.4%
Shinva Medical InstrumentLtd
Market Cap: CN¥9.3b
Provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People’s Republic of China.
600587
CN¥15.25
7D
-1.6%
1Y
-6.7%
Zhende Medical
Market Cap: CN¥5.3b
Engages in the research and development, production, and sale of medical care and protective equipment in China.
603301
CN¥20.07
7D
-3.6%
1Y
-1.3%
Innovita Biological Technology
Market Cap: CN¥4.2b
A biopharmaceutical enterprise, focuses on the research and development, production and sales of POCT rapid diagnostic products.
688253
CN¥30.78
7D
-6.2%
1Y
-23.9%
Chongqing Xishan Science & Technology
Market Cap: CN¥2.8b
Chongqing Xishan Science & Technology Co., Ltd.
688576
CN¥62.50
7D
-1.6%
1Y
4.2%